A novel role mediated by adenoviral E1A in suppressing cancer through modulating decorin
Yan Ge1,2, Wen Zhang1, Jing Qin1
1Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Abstract:
Oncolytic adenovirus is an emerging alternative to current therapeutics. The adenoviral E1A, the first protein expressed upon oncolytic adenoviral infection, has been identified as an antitumor agent, but the mechanisms of its tumor inhibition ability are unclear enough. Decorin is ubiquitous in the extracellular matrix (ECM), which regulates multiple functions through interaction with ECM. Here, we intended to explore the effects of adenoviral E1A on the tumor extracellular matrix during gene therapy. We demonstrated that reduced decorin expression was found in patients with lung cancer. The adenoviral E1A or a mutant adenoviral E1A with Rb-binding ability absent (E1A 30-60aa, 120-127aa deletion) could increase the expression of decorin and down-regulate VEGF, two members of tumor ECM, involved in both vasculogenesis and angiogenesis. E1A/mE1A-mediated suppressing the migration and invasion ability of tumor cells was depended on decorin. E1A interacted with decorin directly and induced the proteasomal degradation of VEGF. In addition, E1A or mE1A can inhibit tumor growth in a subcutaneous lung cancer xenograft model. It suggested that decorin might be a crucial mediator among ECM components for adenoviral E1A-mediated antitumor activities. These studies on adenovirus E1A provide a new mechanism for the emerging therapies of tumor gene therapy.
Insights
Adenoviral E1A protein enhances decorin expression and reduces VEGF, inhibiting lung cancer cell migration and invasion. This mechanism, mediated by decorin, offers a novel approach for oncolytic adenovirus gene therapy.
Area of Science:
- Oncolytic virotherapy
- Cancer extracellular matrix biology
- Gene therapy
Background:
- Oncolytic adenoviruses show therapeutic potential, but mechanisms of tumor inhibition by adenoviral E1A protein are not fully understood.
- Decorin, an extracellular matrix component, plays a role in regulating cellular functions.
- Reduced decorin expression is observed in lung cancer patients.
Purpose of the Study:
- To investigate the impact of adenoviral E1A on the tumor extracellular matrix during gene therapy.
- To elucidate the role of decorin in adenoviral E1A-mediated antitumor activity.
Main Methods:
- Analysis of decorin expression in lung cancer patients.
- Treatment of lung cancer cells and xenografts with adenoviral E1A and a mutant E1A.
- Assessment of decorin and VEGF expression, cell migration, invasion, and tumor growth.
- Investigation of E1A-decorin interaction and VEGF degradation pathways.
Main Results:
- Adenoviral E1A and a mutant E1A (lacking Rb-binding ability) increased decorin expression and decreased VEGF levels in tumor cells.
- Decorin mediated the suppression of lung cancer cell migration and invasion by E1A/mutant E1A.
- E1A directly interacted with decorin and promoted proteasomal degradation of VEGF.
- E1A and mutant E1A inhibited tumor growth in a lung cancer xenograft model.
Conclusions:
- Decorin is a crucial mediator of adenoviral E1A-mediated antitumor effects by modulating the tumor extracellular matrix.
- Adenoviral E1A's ability to upregulate decorin and downregulate VEGF presents a novel mechanism for oncolytic adenovirus gene therapy against lung cancer.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Abnormal Proliferation


